Distal Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Distal Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy [NA]
A clinical trial evaluating outcomes after laparoscopic versus open pancreaticoduodenectomy for pancreatic and periampullary cancers is curr…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma [Phase 2]
Phase 2 clinical trial evaluating durvalumab in combination with intraductal radiofrequency ablation for unresectable extrahepatic cholangio…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer [NA]
The ToPanc trial is evaluating survival after total versus partial pancreaticoduodenectomy for pancreatic head adenocarcinoma, distal cholan…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC [Phase 2]
Phase 2 trial evaluating first-line radiotherapy combined with hepatic arterial infusion chemotherapy for unresectable distal cholangiocarci…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating durvalumab and tremelimumab with or without capecitabine as adjuvant therapy for biliary tract cancers; th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma [Phase 2, Phase 3]
A Phase 2/3 clinical trial compares neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab versus upfront surgery in patient…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating toripalimab in combination with capecitabine as postoperative adjuvant therapy for resectable extrahepatic biliary …
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma
The clinical trial update reports that a study evaluating the role of adjuvant chemotherapy in distal cholangiocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy [Phase 1, Phase 2]
Clinical trial update on preoperative radiotherapy for patients at high risk of postoperative pancreatic fistula following pancreatoduodenec…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating MK-2206 in patients with advanced biliary cancers (including hepatocellular carcinoma and gallbladder/extrahepatic …